Loading
Loading
Your feedback directly shapes Sporos.
Sign in to track your feedback history
The Food and Drug Administration (FDA, the Agency, or we) is amending its medical device regulations. These revisions are necessary to reflect changes to the Agency's Center for Devices and Radiological Health's organizational structure, including the reorganization of its offices. The revisions replace references to the obsolete offices and positions with the current information, update the physical addresses for such offices, and correct inaccurate citations. In addition, as part of this effort we made other editorial non-substantive changes to correct other addresses, references, and citations, as appropriate. The rule does not impose any new regulatory requirements on affected parties. This action is editorial in nature and is intended to improve the accuracy of the Agency's regulations.
Published
Apr 2, 2020
Effective
Apr 1, 2020
Citation
85 FR 18439
Agencies
2
Full text not available in our database.
View on Federal Register →Get a plain-English explanation of what this regulation does, which agencies are responsible, and how it affects existing rules.
No document text available yet
Docket No. FDA-2020-N-0011
21 CFR 5
21 CFR 801
21 CFR 803
21 CFR 807
21 CFR 814
21 CFR 820
21 CFR 821
21 CFR 822
21 CFR 830
21 CFR 860
21 CFR 884
21 CFR 900
21 CFR 1002